Acute viral infection can weaken immunity in mice for a long time

• Immune dysfunction persisted in recovered mice after the virus was cleared
• The infection was accompanied by spleen fibrosis and disrupted organization of immune cells
• No such changes were detected in mice vaccinated before infection; whether the effect occurs in humans has not been established

What the experiment showed after recovery

Researchers from the Infection Biology Laboratory at Pompeu Fabra University studied what happens to the immune system after an acute viral infection. They used mice that had been infected and had overcome the virus. However, the pathogen’s disappearance did not mean that all immune functions had returned to normal: the animals continued to show abnormalities, which were evident even after the acute illness had ended.

The finding calls into question the simple notion that recovery means the body fully returns to its original state as soon as symptoms disappear. The viral infection in the experiment was acute, not ongoing: the researchers report effects that persisted after the virus was brought under control. This distinction matters—the pathogen was not still detectable; rather, changes in the body’s defenses continued.

The study was published in the journal Cell Death & Disease. The team monitored the mice’s immune systems after infection and compared the effects with those in animals that had previously received a vaccine. The study looked not only at whether the body was able to clear the virus, but also at how the infection affected its ability to respond to new threats. The details in the source relate specifically to this animal model.

Changes in the spleen were linked to T-cell activity

The researchers found key changes in the spleen, an organ involved in coordinating immune defenses. As the body fought the virus, fibrosis developed in the spleen, with scar-like tissue building up. The location and organization of immune cells were also disrupted. Thus, the effects involved not just individual cells, but also the structure of an organ where important interactions within the immune system take place.

According to the researchers, remodeling of the spleen disrupted the interactions between immune cells needed to activate T cells. These specialized cells are part of the adaptive immune system: they help recognize and destroy infected cells. When the necessary interactions are disrupted, the response to a new threat may be less effective. The authors link the persistent problems with immune defense after infection to these structural changes.

As a result, the recovered mice were less able to cope with subsequent immune challenges, even though the initial infection had already been brought under control. The study’s first author, Paula Cebollada Rica, stressed that eliminating the infection does not in itself prove that the body has fully recovered. In this experiment, the effects took the form of impaired immune function and changes to the spleen; the source does not claim that this condition necessarily occurs after every viral infection.

Prior vaccination changed the outcome

After detecting lasting abnormalities, the researchers tested whether they could be prevented by vaccination before infection. The vaccine prepares the immune system in advance to recognize and fight the pathogen. In the experiment, mice vaccinated in advance differed from animals that had gone through the infection without this preparation: they showed none of the described changes to the spleen or T-cell dysfunction.

In the vaccinated animals, the spleen’s structure remained normal, and T cells continued to function at levels comparable to those in mice that had not been infected at all. This comparison suggests that immune functions were preserved in this model. However, the study does not show that vaccination protects against every consequence of all viral infections: the conclusion applies to the acute infection studied and to the experiment in mice.

The authors view the result as a possible additional benefit of vaccination: protection may extend beyond the illness caused by the current infection to the immune system’s ability to respond to later threats. In the experiment, mice vaccinated beforehand avoided the changes seen in another group after recovery. But this does not prove that the same effect occurs in humans, nor does it allow its scale to be assessed beyond the experiment.

Why the findings cannot yet be applied to humans

The main limitation of the study is that it was conducted in mice. The data alone do not establish that people undergo the same changes in the spleen and T cells after an acute viral infection, or that prior vaccination prevents them. The authors explicitly acknowledge this uncertainty. The results therefore broaden the scope of questions for future research, but do not provide a definitive answer about the long-term effects of common infections in humans.

The study also does not allow us to conclude that all viruses, vaccines, or vaccination schedules produce the same result. The source describes a specific experiment but does not name the virus, vaccine type, doses, or follow-up period needed for broader comparisons. Nor can we determine how long the impairments persisted in the mice beyond the reported fact that they outlasted the period when the virus was no longer detectable.

The practical significance of the work at this stage is that assessing recovery may require attention not only to the disappearance of symptoms and the virus itself, but also to possible effects on immune function. At the same time, the study does not by itself change medical recommendations for people or prove a clinical effect of vaccination in this situation. The next important question is whether the observations in animals will be confirmed in studies of human immunity.

Source: ScienceDaily